1201 - 1225 of 6568 Results
Title
Year
- Preclinical evaluation of nitrated α-synuclein-specific CAR-Treg therapy in Parkinson’s disease2026OPENTitle: Preclinical evaluation of nitrated α-synuclein-specific CAR-Treg therapy in Parkinson’s diseaseJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 7Issue #: 9Start Page: 102983End Page: 102983Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xcrm.2026.102983Best OA location URL: https://doi.org/10.1016/j.xcrm.2026.102983Citation Count: 0
-
OPENTitle: An automated workflow for quantifying the formation of synuclein aggregates in human dopaminergic neuronsJournal Name: MethodsPublisher: Elsevier BVVol: 254Issue #:Start Page: 29End Page: 41Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymeth.2026.06.005Best OA location URL: https://doi.org/10.1016/j.ymeth.2026.06.005Citation Count: 0
- Protocol for classifying cellular senescence from single-cell and single-nucleus RNA sequencing data2026OPENTitle: Protocol for classifying cellular senescence from single-cell and single-nucleus RNA sequencing dataJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 7Issue #: 3Start Page: 104724End Page: 104724Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xpro.2026.104724Best OA location URL: https://doi.org/10.1016/j.xpro.2026.104724Citation Count: 0
- Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research2021OPENTitle: Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical researchJournal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page: 322End Page: 322Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-021-05273-xBest OA location URL: https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-021-05273-xCitation Count: 45
-
OPENTitle: Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 4Start Page: 534End Page: 540Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13168Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/134137Citation Count: 30
-
OPENTitle: Plasma phosphorylated tau217 discordance with amyloid status in an ethnically diverse mixed memory clinic cohortJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 488Issue #:Start Page: 126057End Page: 126057Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jns.2026.126057Best OA location URL: https://www.jns-journal.com/article/S0022-510X(26)00339-4/pdfCitation Count: 1
-
OPENTitle: Paratonia in Advanced Dementia: Deconstructing Scientific, Regulatory, and Health System Barriers to Botulinum Toxin A (BoNT-A) Treatment of Involuntary Muscle ResistanceJournal Name: Journal of the American Medical Directors AssociationPublisher: Elsevier BVVol: 27Issue #: 7Start Page: 106285End Page: 106285Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jamda.2026.106285Best OA location URL: https://www.jamda.com/article/S1525-8610(26)00175-1/pdfCitation Count: 0
-
OPENTitle: Apoptosis protein markers in comorbid type 2 diabetes mellitus and depression; relationships with cognitive performance, incident dementia, and white matter hyperintensitiesJournal Name: Journal of Affective DisordersPublisher: Elsevier BVVol: 414Issue #:Start Page: 122353End Page: 122353Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jad.2026.122353Best OA location URL: https://doi.org/10.1016/j.jad.2026.122353Citation Count: 0
-
OPENTitle: Single-cell RNA profiling of oligodendroglial lineage cells derived from iPSCs carrying Parkinson’s disease-relevant LRRK2-G2019S mutationJournal Name: iSciencePublisher: Elsevier BVVol: 29Issue #: 7Start Page: 116368End Page: 116368Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2026.116368Best OA location URL: https://doi.org/10.1016/j.isci.2026.116368Citation Count: 0
-
OPENTitle: High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cellsJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 2Issue #: 2Start Page: 100463End Page: 100463Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xpro.2021.100463Best OA location URL: https://doi.org/10.1016/j.xpro.2021.100463Citation Count: 24
-
OPENTitle: Hypertension acts together with Aβ pathology in late-life to promote memory lossJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 13Issue #: 7Start Page: 100579End Page: 100579Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.tjpad.2026.100579Best OA location URL: https://doi.org/10.1016/j.tjpad.2026.100579Citation Count: 0
-
OPENTitle: Identification of genes associated with smell dysfunction in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 14Issue #:Start Page: 100453End Page: 100453Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2026.100453Best OA location URL: https://doi.org/10.1016/j.prdoa.2026.100453Citation Count: 0
-
OPENTitle: Continuous subcutaneous foslevodopa/foscarbidopa in advanced Parkinson's disease: A clinical workflow from 50 consecutive patients at a single U.S. centerJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 15Issue #:Start Page: 100492End Page: 100492Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.prdoa.2026.100492Best OA location URL: https://www.sciencedirect.com/science/article/pii/S2590112526000721/pdfCitation Count: 0
-
OPENTitle: Shortened olfactory identification testing to differentiate parkinsonian syndromesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 149Issue #:Start Page: 108372End Page: 108372Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2026.108372Best OA location URL: https://doi.org/10.1016/j.parkreldis.2026.108372Citation Count: 0
-
OPENTitle: Insulin like growth factor and cytokine signalling predict future cognitive impairment in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 228Issue #:Start Page: 107570End Page: 107570Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2026.107570Best OA location URL: https://doi.org/10.1016/j.nbd.2026.107570Citation Count: 0
-
OPENTitle: Plasma proteomes of obesity and allometric body shapes in the EPIC cohortJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41598-026-64282-5Best OA location URL: https://www.nature.com/articles/s41598-026-64282-5_reference.pdfCitation Count: 0
-
OPENTitle: Fully-automated sleep staging for Parkinson’s disease and isolated REM sleep behavior disorderJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-026-02946-2Best OA location URL: https://doi.org/10.1038/s41746-026-02946-2Citation Count: 0
-
OPENTitle: Cholinergic deficits and hallucinations in Parkinson diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-026-01525-2Best OA location URL: https://www.nature.com/articles/s41531-026-01525-2_reference.pdfCitation Count: 0
-
OPENTitle: In situ architecture of neuronal α-Synuclein inclusionsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 2110End Page: 2110Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-22108-0Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/123519Citation Count: 123
-
OPENTitle: Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolitesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 141Issue #: 5Start Page: 725End Page: 754Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02285-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02285-4.pdfCitation Count: 61
-
OPENTitle: Amantadine ER (Gocovri®) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 645706End Page: 645706Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.645706Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.645706/pdfCitation Count: 24
-
OPENTitle: Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar DegenerationJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 2Start Page: 105End Page: 116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000959Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8032415Citation Count: 6
-
OPENTitle: Sequence of clinical and neurodegeneration events in Parkinson’s disease progressionJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 3Start Page: 975End Page: 988Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/brain/awaa461Best OA location URL: https://academic.oup.com/brain/article-pdf/144/3/975/37036706/awaa461.pdfCitation Count: 100
-
OPENTitle: Healing helminths: The disease-modifying potential of helminth-derived proteins in animal models of inflammatory disease - a systematic reviewJournal Name: Molecular TherapyPublisher: Elsevier BVVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.ymthe.2026.08.038Best OA location URL: https://doi.org/10.1016/j.ymthe.2026.08.038Citation Count: 0
-
OPENTitle: Cholesterol dysregulation in APOE4 astrocytes promotes α-synuclein pathology in miBrainsJournal Name: Cell Stem CellPublisher: Elsevier BVVol: 33Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.stem.2026.08.001Best OA location URL: https://doi.org/10.1016/j.stem.2026.08.001Citation Count: 0